Whilst it’s known that TGF-β signaling stimulates tumor progression through immune evasion, promotion of angiogenesis and the activation of cancer associated fibroblasts (CAFs), such effects on tumor stroma, which in part are also mediated by epigenetic changes, will not be discussed here. Here, TGFB1 is linked to neoplasm.